Did Boehringer Ingelheim launch world_class biopharmaceuticals manufacturing site in China
0
Boehringer Ingelheim launched world_class biopharmaceuticals manufacturing site in China <EOP> .
launched	2	CT+	CT+
########
1
2017_05_17 21:46 <EOP> .
########
2
chinadaily.com.cn <EOP> .
########
3
German pharmaceutical giant Boehringer Ingelheim announced Tuesday that its China Biopharmaceuticals Site has officially been put into operation .
put	15	CT+	CT+
########
4
As the first and only biopharma site set up in line with global standards by a multinational pharma company in China , the site has become a major milestone in Boehringer Ingelheim 's strategic blueprint for its biopharma business globally .
set	7	CT+	CT+
########
5
<EOP> .
########
6
The first_phase investment has exceeded 70 million euros .
########
7
As Boehringer Ingelheim has been selected as one of the first companies to launch the country 's biopharma CMO pilot projects , the Shanghai_based site will provide all_round services , including process development , clinical and commercial supply , to its customers in China and all over the world .
will	25	ps_cue
########
8
<EOP> .
########
9
The site is located in the core area of Zhangjiang High_tech Park in Pudong , Shanghai .
########
10
Its design , construction and operation system follow top global standards .
########
11
It has the qualification and capacity to supply bio_medicines to countries around the world .
########
12
The site is now running a production line of 2,000 L single_use bioreactor , which is by far the world 's largest disposable bioreactor .
########
13
The site has a designed capacity of four 2000L single_use bioreactors , enabling it to meet greater market demand in the future .
########
14
<EOP> .
########
15
Leveraging Boehringer Ingelheim 's world_class biopharma contract manufacturing platform , Chinese pharma companies will be able to accelerate exploring the European and US markets , and the core competitiveness of China 's biopharma industry will be further strengthened .
will	13	ps_cue
will	34	ps_cue
########
16
Also , multinational pharma companies will take advantage of Boehringer Ingelheim China Biopharmaceuticals Site as a `` bridge '' to quickly enter the China market .
will	5	ps_cue
########
17
<EOP> .
########
18
Setting up the bridge between China and the world 's biopharma market <EOP> .
########
19
As one of the largest biopharma contract manufacturers , Boehringer Ingelheim has successfully marketed 27 biopharmaceuticals in global markets .
########
20
The China Biopharmaceuticals Site in Shanghai is the company 's fourth biopharma site after those in Biberach LRB Germany RRB , Vienna LRB Austria RRB and Fremont LRB USA RRB .
########
21
The Shanghai site will help further improve Boehringer Ingelheim 's global biopharma manufacturing network as a key milestone in its strategic business layout .
will	3	ps_cue
########
22
<EOP> .
########
23
The official launch of the site marks Boehringer Ingelheim has fully kicked off biopharma contract manufacturing service in China .
launch	2	CT+	CT+
########
24
The lab for clinical material supply and the commercial production site have been built upon Boehringer Ingelheim 's global service philosophy in contract manufacturing , which expands from DNA to fill and finish , from process development to commercial production , and from drug assessment to quality assurance .
########
25
With the Shanghai site , Boehringer Ingelheim will serve both Chinese and global customers with its world_class biopharmaceuticals .
will	7	ps_cue
########
26
<EOP> .
########
27
`` Boehringer Ingelheim Biopharmaceuticals China is committed to helping Chinese biopharma companies to serve the domestic market with high_quality bio_medicines , and gradually go beyond the borders into international markets .
########
28
We will also leverage our company 's heritage and global experience to support multinational companies to seek better access to the Chinese biopharma market , '' said Luo Jiali , General Manager of Boehringer Ingelheim Biopharmaceuticals LRB China RRB Co Ltd. `` Boehringer Ingelheim Biopharmaceuticals China will strive to be a bridge that connects China with the world 's biopharma markets , and further benefit patients in China and around the world . ''
will	1	ps_cue
will	46	ps_cue
########
29
<EOP> .
########
